Cui C, et al. - Lysosome-associated protein transmembrane 4 beta-35 (LAPTM4B-35) expression was explored in pancreatic cancer (PC), as well as, the relationship between LAPTM4B-35 expression with clinicopathological features and post-operation survival of PC patients was examined. This study unveiled a correlation of LAPTM4B-35 expression with favorable post-operation survival in these patients. For PC at its early stage, LAPTM4B-35 seemed to act as a candidate biomarker.